Last reviewed · How we verify
NCT03586700
Based on the Ultrasound Evaluating the Effect of Xiaozhong Fang Particles for Knee Osteoarthritic With Synovial Fluid
Phase 2 trial testing Xiao zhong fang granules in Knee Osteoarthritis in 50 participants. Status unknown.
31 August 2020
Quick facts
| Lead sponsor | Beijing University of Chinese Medicine |
|---|---|
| Phase | Phase 2 |
| Status | Status unknown |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | parallel |
| Masking | triple |
| Primary purpose | treatment |
| Enrollment | 50 |
| Start date | 15 September 2017 |
| Primary completion | 31 August 2020 |
| Estimated completion | 31 October 2020 |
| Sites | 1 location across China |
Drugs / interventions tested
- Xiao zhong fang granules — full drug profile →
- Short wave infrared radiation
- Placebo Xiao zhong fang granules
Conditions studied
- Knee Osteoarthritis — all drugs for Knee Osteoarthritis →
Sponsor
Beijing University of Chinese Medicine
Who can join
Eligibility, any sex, with Knee Osteoarthritis. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
This study is a randomized, single blind, controlled trial. Aim to compare the effectiveness (especially the absorption degree of the synovial effusion measured by B ultrasonic) of the treatment group with the control group. The treatment group was given Xiao zhong fang granules orally and short wave infrared radiation and the control group was given the placebo Xiao zhong fang granules orally and short wave infrared radiation. To evaluate the clinical efficacy of the Chinese medicine in the treatment of the synovial effusion of knee osteoarthritis.
Publications & conference data
No peer-reviewed publications indexed yet for this trial.
Verify or expand the search:
- PubMed search for NCT03586700
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Knee Osteoarthritis
Currently open trials in the same condition.
- NCT06906939 — A Randomized Pilot rTMS Trial for Knee Arthritis Pain and Depression · EARLY_PHASE1 · recruiting
- NCT05823727 — Effects of Collagen Peptide Supplementation on Connective Tissue Remodeling, Functional Outcomes, and Wound Healing Afte · NA · recruiting
- NCT07370480 — Knee Osteoarthritis and Thermal Spa Treatment · NA · recruiting
- NCT07507175 — Gastrocnemius Myofascial Release in Females With Knee Osteoarthritis · NA · recruiting
- NCT07386600 — Dexamethasone vs Dexmedetomidine for iPACK + ACB in TKA · NA · recruiting
Other Beijing University of Chinese Medicine trials
Trials by the same sponsor.
- NCT06980636 — A Trial of Shengmai Liquid for Long COVID Fatigue. · Phase 4 · recruiting
- NCT07472777 — Long-term Efficacy of Modified Guilu Erxian Glue for Myasthenia Gravis · completed
- NCT05941598 — Electroacupuncture for Chemotherapy-Related Cognitive Impairment · Phase 2 · unknown
- NCT05508815 — Modified Zhiwang Decoction Combined With Methotrexate in the Treatment of Early Rheumatoid Arthritis · EARLY_PHASE1 · unknown
- NCT03759405 — IPS Differentiated Cardiomyocytes Vein Transplantation for Chronic Heart Failure · Phase 2, PHASE3 · unknown
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT03586700 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Beijing University of Chinese Medicine
- Last refreshed: 16 July 2018
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03586700.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing